Hester Biosciences Ltd
NSE:HESTERBIO

Watchlist Manager
Hester Biosciences Ltd Logo
Hester Biosciences Ltd
NSE:HESTERBIO
Watchlist
Price: 2 408 INR 1.09% Market Closed
Market Cap: 20.5B INR
Have any thoughts about
Hester Biosciences Ltd?
Write Note

Hester Biosciences Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hester Biosciences Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hester Biosciences Ltd
NSE:HESTERBIO
Revenue
â‚ą3.1B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Revenue
â‚ą76.5m
CAGR 3-Years
-57%
CAGR 5-Years
-24%
CAGR 10-Years
-27%
Transgene Biotek Ltd
BSE:526139
Revenue
â‚ą2m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Revenue
â‚ą397.3m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
26%
Biocon Ltd
NSE:BIOCON
Revenue
â‚ą148.9B
CAGR 3-Years
27%
CAGR 5-Years
20%
CAGR 10-Years
18%
Panacea Biotec Ltd
NSE:PANACEABIO
Revenue
â‚ą5.5B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Hester Biosciences Ltd
Glance View

Market Cap
20.5B INR
Industry
Biotechnology

Hester Biosciences Ltd. is a holding company, which engages in the manufacture and trade of poultry vaccines and animal health products. The company is headquartered in Ahmedabad, Gujarat and currently employs 584 full-time employees. Its segments include Poultry division and Animal division. The company provides over 40 products across poultry vaccines (live and inactivated), animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. The company manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. The company offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

HESTERBIO Intrinsic Value
1 593.33 INR
Overvaluation 34%
Intrinsic Value
Price

See Also

What is Hester Biosciences Ltd's Revenue?
Revenue
3.1B INR

Based on the financial report for Sep 30, 2024, Hester Biosciences Ltd's Revenue amounts to 3.1B INR.

What is Hester Biosciences Ltd's Revenue growth rate?
Revenue CAGR 5Y
11%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Hester Biosciences Ltd have been 9% over the past three years , 11% over the past five years .

Back to Top